This labeling scheme excludes both dead cells and hematopoietic cells and enables identification of human tumor EC-like cells (hCD34+), mouse tumor EC-like cells (mCD34+), and GSCs (hCD133+) from the live CD45− pool (Figure 2A). This evidence concerns the gene PTPRC and neoplasm.